The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer - Poll - MDSpire

The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer

  • By

  • Veera Nurmela

  • Anni Juntunen

  • Satu Tiainen

  • Janne Martikainen

  • Sanna Pasonen-Seppänen

  • Aino Rönkä

  • June 23, 2026

  • 0 min

Share

Original Source(s)

The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer

  • by Veera Nurmela, Anni Juntunen, Satu Tiainen, Janne Martikainen, Sanna Pasonen-Seppänen, Aino Rönkä

  • June 23, 2026

Related Content

Distribution analysis of gynecological carcinomas with concurrent second primary carcinomas

The NLRP3 inflammasome in gynecological cancers: a double-edged sword shaping the immune microenvironment and immunotherapy response

Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study